glp 1 vs 2 GLP-1 receptor agonists are increasingly used to treat type diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read GLP-1-based therapies for type 2

Do not use GLP-1 medications if you or your family have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)." Serious Side Effects Requiring Immediate Medical Attention According to prescribing information: Severe abdominal pain potentially indicating pancreatitis Signs of allergic reaction including swelling of face or throat Difficulty breathing Yellowing of skin or eyes Who Should Not Use GLP-1 Medications Per standard prescribing guidance: Individuals who are pregnant, planning to become pregnant, or nursing Individuals with certain pancreatic conditions Individuals with severe gastrointestinal diseases Individuals with personal or family history of MTC or MEN 2 The Prescriber's Role According to the company, licensed clinicians make all prescribing decisions based on the health information you provide

What is InnoSlim and How Does It Compare

Always consult your healthcare provider before making any decisions about your medication regimen, especially related to travel

BPC-157 is popular for gut healing and may help manage GI side effects from GLP-1 activation

We look forward to additional cardiovascular outcome trials in patients with obesity. The trial was sponsored by Novo Nordisk, the company that markets semaglutide